A cluster randomised controlled trial with embedded process evaluation to investigate the clinical and cost effectiveness of multidisciplinary care in the management of patients with a fracture of the hip
Hip fracture
Hospitals will be randomised to the HIPCARE intervention or usual care, via a centralised computer-based process stratified by country and will be carried out in advance of the start of recruitment. Intervention arm: The hospitals allocated to the HIPCARE intervention will be given additional funds to allocate the time of a senior clinician to act as an Intervention Champion. The local Principal Investigator and the Intervention Champion will establish a multi-disciplinary HIPCARE Working Group. HIPCARE intervention hospitals will be provided with a multi-disciplinary training package with online support. This will be focussed on: 1. Reducing delays to surgery, 2. Reducing the time taken for patients to start walking after surgery and 3. speeding up general medical assessment. Control arm: Patients will be treated as per the pre-trial pathways for hip fracture patients.
Patients aged 60 years or over having surgery for a hip fracture.
The participant or a carer cannot complete follow-up at 120 days